Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of sofosbuvir + velpatasvir in Japan
jRCT2080224904Phase 3Completed
- Start
- Oct 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of sofosbuvir and velpatasvir in hepatitis C virus infection. Started Oct 2019; status: completed.
02
Drugs
sofosbuvirvelpatasvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on jRCT2080224904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224904.